A recent study published on the bioRxiv preprint server has shed light on the potential impact of helminth infection on the effectiveness of COVID-19 vaccines. Helminths, which include hookworms, whipworms, and roundworms, infect more than a quarter of the global population. While these infections are usually asymptomatic in healthy individuals, they can cause significant morbidity in immunocompromised individuals and children.
Previous research has shown that helminth infections can negatively affect immune responses to various vaccines, such as those for tuberculosis, hepatitis B, influenza, and measles. However, the impact on the efficacy of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was largely unknown until now.
The study aimed to evaluate how helminth infection affected COVID-19 vaccine efficacy in mice. The researchers used C57BL/6J mice and administered an mRNA vaccine encoding the SARS-CoV-2 Wuhan-1 spike protein. The mice were then infected with Heligmosomoides polygyrus bakeri (Hpb), a common helminth, either before or after vaccination.
The findings of the study revealed that while helminth infection did not significantly impact the production of antibodies in response to the vaccine, but it did affect T-cell responses. Specifically, infected mice showed reduced numbers of certain T-cell subtypes that play a crucial role in immune defence. This impairment was observed regardless of whether the infection occurred before the first vaccine dose or before the booster dose.
Furthermore, the study showed that helminth infection compromised the protection provided by the vaccine against the Omicron BA.5.5 variant of SARS-CoV-2. Infected mice had higher viral burdens and increased levels of viral RNA and infectious virus in their lungs compared to non-infected mice. However, protection against the D614G strain of the virus remained intact.
The researchers also investigated the underlying mechanisms responsible for the impaired T-cell response. They found that helminth-induced production of interleukin-10 (IL-10), a regulatory cytokine, was likely responsible for suppressing the T-cell response to the vaccine. When IL-10 was blocked in infected animals, the vaccine-elicited T-cell response was restored.
These findings highlight the importance of considering helminth infections as potential factors that can modulate the efficacy and immunogenicity of COVID-19 vaccines. While the impact on antibody production may be minimal, the compromised T-cell response and reduced protection against certain variants could have significant implications.
It is important to note that the study published on the bioRxiv preprint server represents preliminary scientific research and has not yet undergone peer review. As such, the findings should be interpreted with caution and further research is needed to validate the results.
Understanding the interactions between helminth infections and COVID-19 vaccines is crucial for optimising vaccine strategies in regions with high helminth prevalence. Future studies should explore potential interventions to mitigate the negative effects of helminth infections on vaccine-induced immune responses.
This study provides valuable insights into the impact of helminth infection on COVID-19 vaccine efficacy. While the production of antibodies may remain unaffected, the compromised T-cell response and reduced protection against certain variants highlight the need for further research and potential interventions to address these challenges.
